Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vishnu C. Damalanka, Amarendar Reddy Maddirala & James W. Janetka. (2021) Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists. Expert Opinion on Drug Discovery 16:5, pages 513-536.
Read now
Read now
Wael Elhenawy, Alexander Oberc & Brian K. Coombes. (2018) A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli. Gut Microbes 9:2, pages 166-174.
Read now
Read now
Adeline Sivignon, Julie Bouckaert, Julien Bernard, Sebastien G. Gouin & Nicolas Barnich. (2017) The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. Expert Opinion on Therapeutic Targets 21:9, pages 837-847.
Read now
Read now
Laurel K. Mydock-McGrane, Thomas J. Hannan & James W. Janetka. (2017) Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease. Expert Opinion on Drug Discovery 12:7, pages 711-731.
Read now
Read now
Articles from other publishers (37)
Hussein Al-Mughaid, Younis Jaradat, Maha Khazaaleh & Ibrahim Al-Taani. (2023) Click chemistry inspired facile one-pot synthesis of mannosyl triazoles and their hemagglutination inhibitory properties: The effect of alkyl chain spacer length between the triazole and phthalimide moieties in the aglycone backbone. Carbohydrate Research 534, pages 108965.
Crossref
Crossref
Nazli Atac, Kubra Onbasli, Irem Koc, Havva Yagci Acar & Fusun Can. (2023)
Fimbria targeting superparamagnetic iron oxide nanoparticles enhance the antimicrobial and antibiofilm activity of ciprofloxacin against quinolone‐resistant
E. coli
. Microbial Biotechnology 16:11, pages 2072-2081.
Crossref
Crossref
Francesco Scaglione, Paola Minghetti, Francesco Ambrosio, Beat Ernst, Vincenzo Ficarra, Marco Gobbi, Kurt Naber & Huub Schellekens. (2023) Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence. Therapeutic Innovation & Regulatory Science 57:6, pages 1153-1166.
Crossref
Crossref
Priyanka Samanta & Robert J. Doerksen. (2023) Identifying FmlH lectin-binding small molecules for the prevention of Escherichia coli-induced urinary tract infections using hybrid fragment-based design and molecular docking. Computers in Biology and Medicine 163, pages 107072.
Crossref
Crossref
Margarida Faustino, Sara Silva, Eduardo M. Costa, Ana Margarida Pereira, Joana Odila Pereira, Ana Sofia Oliveira, Carlos M. H. Ferreira, Carla F. Pereira, Joana Durão, Manuela E. Pintado & Ana P. Carvalho. (2023) Effect of Mannan Oligosaccharides Extracts in Uropathogenic Escherichia coli Adhesion in Human Bladder Cells. Pathogens 12:7, pages 885.
Crossref
Crossref
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Bouckaert & René Roy. (2023) Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15:2, pages 527.
Crossref
Crossref
Anmol GulatiXin Guo. 2022. 2022 Medicinal Chemistry Reviews. 2022 Medicinal Chemistry Reviews
389
414
.
Jun-Young Park, Cheorl-Ho Kim & Seung-Hak Cho. (2022) Glycan-Adhering Lectins and Experimental Evaluation of a Lectin FimH Inhibitor in Enterohemorrhagic Escherichia coli (EHEC) O157:H7 Strain EDL933. International Journal of Molecular Sciences 23:17, pages 9931.
Crossref
Crossref
Kathrin Tomasek, Alexander Leithner, Ivana Glatzova, Michael S Lukesch, Calin C Guet & Michael Sixt. (2022) Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14. eLife 11.
Crossref
Crossref
Hussein Al-Mughaid, Shorooq Nawasreh, Heba Naser, Younis Jaradat & Raed M. Al-Zoubi. (2022) Synthesis and hemagglutination inhibitory properties of mannose-tipped ligands: The effect of terminal phenyl groups and the linker between the mannose residue and the triazole moiety. Carbohydrate Research 515, pages 108559.
Crossref
Crossref
Hussein Al-Mughaid, Younis Jaradat & Maha Khazaaleh. (2022) Synthesis and biological evaluation of mannosyl triazoles and varying the nature of substituents on the terminal phthalimido moiety in the aglycone backbone. Results in Chemistry 4, pages 100548.
Crossref
Crossref
Sweta Karan, Lalit C. Garg, Devapriya Choudhury & Aparna Dixit. (2021) Recombinant FimH, a fimbrial tip adhesin of Vibrio parahaemolyticus, elicits mixed T helper cell response and confers protection against Vibrio parahaemolyticus challenge in murine model. Molecular Immunology 135, pages 373-387.
Crossref
Crossref
Shobana Sundar, Lokesh Thangamani, Shanmughavel Piramanayagam & Jeyakumar Natarajan. (2021) Discovering mycobacterial lectins as potential drug targets and vaccine candidates for tuberculosis treatment: a theoretical approach. Journal of Proteins and Proteomics 12:2, pages 93-104.
Crossref
Crossref
Donald J. AbrahamRoland E. Dolle, Laurel K. McGrane, James W. Janetka, Jared T. Hammill, Rodney Kiplin Guy, Anjan Debnath, Peter M. Cheuka, Claire Le Manach, Kelly Chibale, Ake Elhammer, Martin Handfield, Michael J. Dawson, Stefano Donadio, Jae H. Park & Alan Joslyn. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
95
.
Tihomir Tomašič, Said Rabbani, Roman P. Jakob, Andreas Reisner, Žiga Jakopin, Timm Maier, Beat Ernst & Marko Anderluh. (2021) Does targeting Arg98 of FimH lead to high affinity antagonists?. European Journal of Medicinal Chemistry 211, pages 113093.
Crossref
Crossref
Mutaib M. Mashraqi, Navaneet Chaturvedi, Qamre Alam, Saleh Alshamrani, Mosa M. Bahnass, Khurshid Ahmad, Amany I. Alqosaibi, Mashael M. Alnamshan, Syed Sayeed Ahmad, Mirza Masroor Ali Beg, Abha Mishra, Sibhghatulla Shaikh & Syed Mohd Danish Rizvi. (2021) Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs. Molecules 26:3, pages 582.
Crossref
Crossref
Meysam Sarshar, Payam Behzadi, Cecilia Ambrosi, Carlo Zagaglia, Anna Teresa Palamara & Daniela Scribano. (2020) FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens. Antibiotics 9:7, pages 397.
Crossref
Crossref
Daniela Scribano, Meysam Sarshar, Carla Prezioso, Marco Lucarelli, Antonio Angeloni, Carlo Zagaglia, Anna Teresa Palamara & Cecilia Ambrosi. (2020) d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications. Molecules 25:2, pages 316.
Crossref
Crossref
Leila Mousavifar, Gérard Vergoten, Guillaume Charron & René Roy. (2019) Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH. Molecules 24:19, pages 3566.
Crossref
Crossref
Amarendar Reddy Maddirala, Roger Klein, Jerome S. Pinkner, Vasilios Kalas, Scott J. Hultgren & James W. Janetka. (2018)
Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic
E. coli
(UPEC): Optimization through Iterative Rational Drug Design
. Journal of Medicinal Chemistry 62:2, pages 467-479.
Crossref
Crossref
Katharina Kolbe, Sri Kumar Veleti, Norbert Reiling & Thisbe K Lindhorst. (2019)
Lectins of
Mycobacterium tuberculosis
– rarely studied proteins
. Beilstein Journal of Organic Chemistry 15, pages 1-15.
Crossref
Crossref
Barbara Parrino, Domenico Schillaci, Ilaria Carnevale, Elisa Giovannetti, Patrizia Diana, Girolamo Cirrincione & Stella Cascioferro. (2019) Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. European Journal of Medicinal Chemistry 161, pages 154-178.
Crossref
Crossref
Chrysoula Pipili & Eirini Grapsa. 2019. Clinical Nephrogeriatrics. Clinical Nephrogeriatrics
87
101
.
Néha Sihra, Anna Goodman, Rhana Zakri, Arun Sahai & Sachin Malde. (2018) Nonantibiotic prevention and management of recurrent urinary tract infection. Nature Reviews Urology 15:12, pages 750-776.
Crossref
Crossref
Jitendra A. Sattigeri, Malvika Garg, Pragya Bhateja, Ajay Soni, Abdul Rehman Abdul Rauf, Mahendrakumar Gupta, Mahesh S. Deshmukh, Tarun Jain, Nidhi Alekar, Tarani Kanta Barman, Paras Jha, Tridib Chaira, Ramesh B. Bambal, Dilip J. Upadhyay & Takahide Nishi. (2018) Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors. Bioorganic & Medicinal Chemistry Letters 28:17, pages 2993-2997.
Crossref
Crossref
Eva-Maria Krammer, Jerome de Ruyck, Goedele Roos, Julie Bouckaert & Marc Lensink. (2018) Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation—The Example of FimH. Molecules 23:7, pages 1641.
Crossref
Crossref
Vasilios Kalas, Michael E. HibbingAmarendar Reddy Maddirala, Ryan Chugani, Jerome S. PinknerLaurel K. Mydock-McGrane, Matt S. ConoverJames W. Janetka & Scott J. Hultgren. (2018) Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection. Proceedings of the National Academy of Sciences 115:12.
Crossref
Crossref
Tamas Tornai, David Tornai, Nora Sipeki, Istvan Tornai, Rayan Alsulaimani, Kai Fechner, Dirk Roggenbuck, Gary L. Norman, Gabor Veres, Gabriella Par, Alajos Par, Ferenc Szalay, Peter Laszlo Lakatos, Peter Antal-Szalmas & Maria Papp. (2018) Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. Scientific Reports 8:1.
Crossref
Crossref
J. de Ruyck, G. Roos, E.-M. Krammer, M. Prévost, M. F. Lensink & J. Bouckaert. 2017. Biophysical Techniques in Drug Discovery. Biophysical Techniques in Drug Discovery
67
86
.
Mohamed Touaibia, Eva-Maria Krammer, Tze Shiao, Nao Yamakawa, Qingan Wang, Anja Glinschert, Alex Papadopoulos, Leila Mousavifar, Emmanuel Maes, Stefan Oscarson, Gerard Vergoten, Marc Lensink, Ren? Roy & Julie Bouckaert. (2017) Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin. Molecules 22:7, pages 1101.
Crossref
Crossref
Dimitri Alvarez Dorta, Thibaut Chalopin, Adeline Sivignon, Jérôme de Ruyck, Tetiana I. Dumych, Rostyslav O. Bilyy, David Deniaud, Nicolas Barnich, Julie Bouckaert & Sébastien G. Gouin. (2017)
Physiochemical Tuning of Potent
Escherichia coli
Anti‐Adhesives by Microencapsulation and Methylene Homologation
. ChemMedChem 12:12, pages 986-998.
Crossref
Crossref
Said Rabbani, Eva-Maria Krammer, Goedele Roos, Adam Zalewski, Roland Preston, Sameh Eid, Pascal Zihlmann, Martine Prévost, Marc F. Lensink, Andrew Thompson, Beat Ernst & Julie Bouckaert. (2017)
Mutation of Tyr137 of the universal
Escherichia coli
fimbrial adhesin FimH relaxes the tyrosine gate prior to mannose binding
. IUCrJ 4:1, pages 7-23.
Crossref
Crossref
Cinzia Colombo & Anna Bernardi. 2017. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Jake A. Smith, Guoxi Xu, Ruozhu Feng, James W. Janetka & Kevin D. Moeller. (2016) C‐Glycosides, Array‐based Addressable Libraries, and the Versatility of Constant Current Electrochemistry. Electroanalysis 28:11, pages 2808-2817.
Crossref
Crossref
Laurel Mydock-McGrane, Zachary Cusumano, Zhenfu Han, Jana Binkley, Maria Kostakioti, Thomas Hannan, Jerome S. Pinkner, Roger Klein, Vasilios Kalas, Jan Crowley, Nigam P. Rath, Scott J. Hultgren & James W. Janetka. (2016)
Antivirulence
C
-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections
. Journal of Medicinal Chemistry 59:20, pages 9390-9408.
Crossref
Crossref
Jerome de Ruyck, Marc F. Lensink & Julie Bouckaert. (2016)
Structures of
C
-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin
. IUCrJ 3:3, pages 163-167.
Crossref
Crossref
Cassie Jarvis, Zhenfu Han, Vasilios Kalas, Roger Klein, Jerome S. Pinkner, Bradley Ford, Jana Binkley, Corinne K. Cusumano, Zachary Cusumano, Laurel Mydock-McGrane, Scott J. Hultgren & James W. Janetka. (2016) Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI. ChemMedChem 11:4, pages 367-373.
Crossref
Crossref